Griscelli syndrome type 3

From WikiMD's WELLNESSPEDIA

Autosomal recessive - en
Griscelli syndrome type 3






Symptoms Hypopigmentation, Neurological abnormalities





Causes Genetic mutation


Diagnosis Genetic testing



Treatment Bone marrow transplant, Immunotherapy






Griscelli syndrome type 3 is a rare genetic disorder characterized by hypopigmentation and neurological abnormalities. It is one of the three types of Griscelli syndrome, which also includes Griscelli syndrome type 1 and Griscelli syndrome type 2. This condition is caused by mutations in the gene encoding the protein melanophilin (MLPH).

Presentation[edit]

Individuals with Griscelli syndrome type 3 typically present with hypopigmentation of the skin and hair. Unlike the other types of Griscelli syndrome, type 3 does not usually involve severe immunodeficiency or neurological impairment. However, some patients may exhibit mild neurological abnormalities.

Genetics[edit]

Griscelli syndrome type 3 is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The responsible gene, MLPH, plays a crucial role in the transport of melanosomes, which are cellular structures involved in the production and distribution of melanin.

Diagnosis[edit]

The diagnosis of Griscelli syndrome type 3 is typically confirmed through genetic testing that identifies mutations in the MLPH gene. Clinical evaluation of hypopigmentation and family history can also aid in the diagnosis.

Treatment[edit]

There is no cure for Griscelli syndrome type 3, but treatment focuses on managing symptoms. Bone marrow transplant and immunotherapy may be considered in some cases, particularly if there are associated immune system abnormalities.

See also[edit]

References[edit]



This genetic disorder related article is a stub. You can help WikiMD by expanding it.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.